EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient-Selection of a Clinical Trial Primary Outcome: The ENHANCE-AF Outcomes Survey

Randall S Stafford, Eli N Rice iD, Rushil Shah, Mellanie T Hills, Julio C Nunes, Katie DeSutter, Amy Lin, Karma Lhamo, Bryant Lin, Ying Lu, Paul J Wang

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0318858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Randall S Stafford und 10 weiteren Autor:innen. Beteiligte Einrichtung: Stanford University School of Medicine, Stanford Prevention Research Center, Stanford, California, United States of America. Hauptthemen laut MEDLINE: Atrial Fibrillation, Patient Selection, Stroke. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association (AHA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Before the initiation of the ENHANCE-AF clinical trial, which tested a novel digital shared decision-making tool to guide the use of anticoagulants in stroke prevention for patients with atrial fibrillation, this study aimed to identify the most appropriate, patient-selected primary outcome and to examine whether outcome selection varied by demographic and clinical characteristics.

Methods

Our cross-sectional survey asked 100 participants with atrial fibrillation to rank two alternative scales based on the scales’ ability to reflect their experiences with decision-making for anticoagulation. The Decisional Conflict Scale (DCS), a 16-item scale, measures perceptions of uncertainty in choosing options. The 5-item Decision Regret Scale (DRS) focuses on remorse after a healthcare decision. We included adults with non-valvular AFib and CHA 2 DS 2 VASc scores of at least 2 for men and 3 for women. Multivariable logistic regression with backward selection identified characteristics independently associated with scale choice.

Results

The DCS was chosen over the DRS by 77% [95% confidence interval (CI) 68 to 85%] of participants. All subgroups designated a preference for the DCS. Those with higher CHA 2 DS 2 VASc scores (≥5, n = 26) selected the DCS 54% of the time compared with 86% of those with lower scores (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPatient SelectionStrokeHumansMaleFemaleAgedMiddle AgedCross-Sectional StudiesSurveys and QuestionnairesAnticoagulantsClinical Trials as TopicAdultDecision Making

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Stanford University School of Medicine, Stanford Prevention Research Center, Stanford, California, United States of America.
  • Stanford University School of Medicine, Center for Clinical Research, Stanford, California, United States of America.
  • Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, United States of America.
  • Stop Afib.org, Greenwood, Texas, United States of America.
  • Department of Psychiatry, Yale University, New Haven, Connecticut, United States of America.
  • Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California, United States of America.

ORCID-Profile: Eli N Rice

Förderung

  • American Heart Association (AHA)

Zitieren

APA

Stafford, R. S., Rice, E. N., Shah, R., Hills, M. T., Nunes, J. C., DeSutter, K., Lin, A., Lhamo, K., Lin, B., Lu, Y., & Wang, P. J. (2025). Patient-Selection of a Clinical Trial Primary Outcome: The ENHANCE-AF Outcomes Survey. PLOS ONE. https://doi.org/10.1371/journal.pone.0318858

Vancouver

Stafford RS, Rice EN, Shah R, Hills MT, Nunes JC, DeSutter K, et al. Patient-Selection of a Clinical Trial Primary Outcome: The ENHANCE-AF Outcomes Survey. PLOS ONE. 2025. doi:10.1371/journal.pone.0318858

BibTeX
@article{Stafford2025,
  author = {Stafford, Randall S and Rice, Eli N and Shah, Rushil and Hills, Mellanie T and Nunes, Julio C and DeSutter, Katie and Lin, Amy and Lhamo, Karma and Lin, Bryant and Lu, Ying and Wang, Paul J},
  title = {Patient-Selection of a Clinical Trial Primary Outcome: The ENHANCE-AF Outcomes Survey},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0318858}
}
Kostenlos starten →